ea0089o1 | Other | NANETS2022
Das, MD, MSCI Satya
, Phillips, MSPH Sharon
, M Lebeck Lee, MD Cody
, Agarwal, MD, MSCI Rajiv
, Bergsland, MD Emily
, Strosberg, MD Jonathan
, A. Chan, MD, MPH Jennifer
, LaFerriere, MLIS Heather
, A. Ramirez, DO Robert
, Berlin, MD Jordan
, Arvind Dasari, MD, MS and
Background: Although anti-VEGF RTKIs have been tested in patients with NETs over the last 2 decades, no study to date has benchmarked efficacy and toxicity of these drugs in this patient population.Methods: A literature search was performed to identify all phase II and phase III studies of anti-VEGF RTKIs in patients with NETs published between January 1, 2000 July 31, 2021. Major trial databases (e.g. Medline, EMBASE, Cumulative Index of Nursing ...